Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-30

Clinical Trial Update: Azelaic Acid on Demodex Counts in Rosacea [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial updates evaluate azelaic acid for reducing Demodex counts in rosacea; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelaic acid (azelaic acid)

Snippet

Sponsor: Wake Forest University | Conditions: Rosacea | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-05-30